Financial
FY2026 revenue $4.81bn (+21.7%); operating margin -6.1%; net loss $162.5m.
Cash $5.23bn; debt $745.5m.
HQ United States · North America
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
FY2026 revenue $4.81bn (+21.7%); operating margin -6.1%; net loss $162.5m.
Cash $5.23bn; debt $745.5m.
Source: official results release · Year ended 2026-01-31 · Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
| Year | Revenue | Growth | Operating profit | Net income | Covers |
|---|---|---|---|---|---|
| FY2026 | US$4.8bn | +21.7% | -US$293.3m | -US$162.5m | CrowdStrike |
Products not yet catalogued.
FY2026 revenue $4.81bn (+21.7%); operating margin -6.1%; net loss $162.5m.
Cash $5.23bn; debt $745.5m.
Jan 2026: A US judge dismissed a shareholder lawsuit over the July 2024 global outage (investors may amend). Delta Air Lines' suit continues after a May 2025 ruling let gross negligence and computer trespass claims proceed; CrowdStrike disputes it and has countersued.
Nov 2025: CrowdStrike dismissed an employee who shared internal screenshots with a hacking group; the company said its systems were never compromised and customers remained protected. NHS DSPT status not yet checked.
Cyber security software supplier; no regulatory or clinical safety actions found in the last 24 months.
Jul 2025: NHS Business Services Authority awarded a framework call-off worth up to £150,000 for CrowdStrike vulnerability management and cloud security, supplied via reseller Softcat, running to Dec 2026.
No competitors linked yet.